Abstract | OBJECTIVE: DESIGN: Placebo-controlled, blinded, multicenter, randomized controlled trial. SETTING: PARTICIPANTS: INTERVENTION: Extended-release niacin monotherapy (48 weeks; n=31) on a dose-titration schedule versus matched placebo (n=23). MAIN OUTCOME MEASURES: RESULTS: Significant increases in fasting HDL-C levels (24.5%) were accompanied by decreases in TC/HDL-C and LDL-C/HDL-C ratios, LDL-C levels, and TC levels (all P<.05). No evidence of sustained hepatotoxicity or hyperglycemia was observed. Treatment-emergent withdrawals (12.9%) accompanied flushing (n=1), hypotension/ presyncope (n=1), and diarrhea (n=2). One subject experienced transient hyperuricemia. Other drug-reported symptoms did not differ from those for placebo. CONCLUSIONS: Extended-release niacin monotherapy is safe, tolerated, and effective for most persons with chronic tetraplegia. Special precautions for changes in bowel habits and postadministration hypotension should be observed.
|
Authors | Mark S Nash, John E Lewis, Trevor A Dyson-Hudson, Yaga Szlachcic, Florence Yee, Armando J Mendez, Ann M Spungen, William A Bauman |
Journal | Archives of physical medicine and rehabilitation
(Arch Phys Med Rehabil)
Vol. 92
Issue 3
Pg. 399-410
(Mar 2011)
ISSN: 1532-821X [Electronic] United States |
PMID | 21276961
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | Copyright © 2011 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Delayed-Action Preparations
- Hypolipidemic Agents
- Triglycerides
- Niacin
- Cholesterol
|
Topics |
- Adolescent
- Adult
- Aged
- Cholesterol
(blood)
- Chronic Disease
- Delayed-Action Preparations
- Double-Blind Method
- Dyslipidemias
(complications, drug therapy)
- Female
- Humans
- Hypolipidemic Agents
(administration & dosage, adverse effects, therapeutic use)
- Male
- Middle Aged
- Niacin
(administration & dosage, adverse effects, therapeutic use)
- Quadriplegia
(complications)
- Triglycerides
(blood)
- Young Adult
|